Prasanthi Meagher, MD
Rheumatology · Saint Paul, MNNPI 1548347594
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $100 of the $100 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Cardinal Health 110 LLC.
Across 1 payment — averaging $100.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardinal Health 110 LLC$100
What the payments were for
- Consulting fees$100100%
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardinal Health 110 LLC | 1 | $100 |
How this compares
$100 in reported general payments places this provider in the 55th percentile of 121 rheumatology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 83 | $601,601 |
| Humira PenAdalimumab | 49 | $483,443 |
| Humira(Cf) PenAdalimumab | 34 | $288,042 |
| XeljanzTofacitinib Citrate | 52 | $246,379 |
| EnbrelEtanercept | 22 | $163,646 |
| Cosentyx SyringeSecukinumab | 14 | $105,946 |
| Taltz AutoinjectorIxekizumab | 13 | $87,854 |
| Xeljanz XrTofacitinib Citrate | 14 | $80,487 |
| Actemra ActpenTocilizumab | 13 | $59,652 |
| ActemraTocilizumab | 12 | $53,732 |
| OrenciaAbatacept/Maltose | 11 | $47,645 |
| MethotrexateMethotrexate Sodium | 793 | $22,618 |
| Hydroxychloroquine Sulfate | 461 | $20,663 |
| Cevimeline Hcl | 43 | $9,139 |
| Leflunomide | 148 | $7,533 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Saint Paul
- Jasmeen UppalSaint Paul$1K
- Thomas IrvinSaint Paul$359
- Michele ObertSaint Paul$315
- David EwartSaint Paul$250
- Matthew McElweeSaint Paul$142
- Martha GranditsSaint Paul$119
- Rayhaan AkramSaint Paul$100
- Asim KhanMaple Grove$1.2M
- Parastoo FazeliMinneapolis$149K
- Robert TierneySt Louis Park$137K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.